Ceritinib + Ketoconazole Interaction
Unknowninteraction on record
Description
( 7.2 ) 7.1 Effect of Other Drugs on ZYKADIA Strong CYP3A Inhibitors A strong CYP3A4/P-gp inhibitor (ketoconazole) increased the systemic exposure of ceritinib [see Clinical Pharmacology (12.3)] , which may increase the incidence and severity of adverse reactions of ZYKADIA.
Source: FDA drug label - ceritinib